Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
The high cost of spasticity in multiple sclerosis to individuals and society.
Potassium channel KIR4.1-specific antibodies in children with acquired demyelinating CNS disease.
Neural correlates of alerting and orienting impairment in multiple sclerosis patients.
Oral fingolimod reduces glutamate-mediated intracortical excitability in relapsing-remitting multiple sclerosis.
Does Slowed Processing Speed Account for Executive Deficits in Multiple Sclerosis? Evidence From Neuropsychological Performance and Structural Neuroimaging.
Managing treatment fatigue in patients with multiple sclerosis on long-term therapy: the role of multiple sclerosis nurses.
Designed Glucopeptides Mimetics of Myelin Protein Epitopes As Synthetic Probes for the Detection of Autoantibodies, Biomarkers of Multiple Sclerosis.
S1P1 Receptor Upregulation and Amelioration of Experimental Autoimmune Encephalomyelitis by an S1P1 Antagonist.
Coincidence of spinal tumor (astrocytoma) and non-specific encephalomyelitis.
Interleukin-10 expression during the acute phase is a putative prerequisite for delayed viral elimination in a murine model for multiple sclerosis.
[Amino acids content in the blood serum of patients with multiple sclerosis.]
Search for cellular stress biomarkers in lymphocytes from patients with multiple sclerosis: a pilot study.
Histone deacetylase activity is required for human oligodendrocyte progenitor differentiation.
Initiation of Anti-TNF Therapy and the Risk of Optic Neuritis; From the Safety Assessment of Biologic ThERapy (SABER) Study.
The hepatocyte growth factor (HGF)-MET receptor tyrosine kinase signaling pathway: Diverse roles in modulating immune cell functions.
The Choroid Plexus in Healthy and Diseased Brain.
CSF cytokines/chemokines as biomarkers in neuroinflammatory CNS disorders: A systematic review.
Medical marijuana in neurology.
Patient and equipment profile for wheelchair seating clinic provision.
Inflammation-independent defective early B cell tolerance checkpoints in rheumatoid arthritis.
Cell fusion in the brain: two cells forward, one cell back.
Blocking LINGO-1 as a Therapy to Promote CNS Repair: From Concept to the Clinic.
Gene Therapy of Multiple Sclerosis Using Interferon β -Secreting Human Bone Marrow Mesenchymal Stem Cells.
Estrogen inhibits estrogen receptor(ER) α-mediated rho-kinase expression in experimental autoimmune encephalomyelitis rats.
Idiopathic inflammatory demyelinating diseases of the brainstem.
Pages
« first
‹ previous
…
302
303
304
305
306
307
308
309
310
…
next ›
last »